Aerie Pharmaceuticals Completes $125M Financing

Newport Beach-based pharmaceuticals developer Aerie Pharmaceuticals said late Tuesday that it has completed its $125M, convertible note financing from Deerfield Management Company. The financing deal had been announced earlier in the month. Aerie Pharmaceuticals is focused on the development and commercialization of treatments for glaucoma. The company said the new funds are expected to fund its known clinical requirements for its lead compounds, and will also go towards general corporate purposes and strategic growth. Aerie is publicly listed on the NASDAQ as AERI.